Petr Pavek

EXPRESSION AND FUNCTIONAL ACTIVITY OF BREAST CANCER RESISTANCE PROTEIN (BCRP, ABCG2) TRANSPORTER IN THE HUMAN CHORIOCARCINOMA CELL LINE BEWO

P. Pávek, M. Ceckova, A. Libra, 2006, Clinical and experimental pharmacology & physiology.

Human Breast Cancer Resistance Protein: Interactions with Steroid Drugs, Hormones, the Dietary Carcinogen 2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and Transport of Cimetidine

Alfred H. Schinkel, P. Pávek, A. Schinkel, 2005, Journal of Pharmacology and Experimental Therapeutics.

Lack of Interactions between Breast Cancer Resistance Protein (BCRP/ABCG2) and Selected Antiepileptic Agents

P. Pávek, F. Staud, L. Červený, 2006, Epilepsia.

P-glycoprotein in the placenta: expression, localization, regulation and function.

P. Pávek, F. Staud, Petr Pavek, 2006, Reproductive toxicology.

P-glycoprotein expression and distribution in the rat placenta during pregnancy.

Martin Kopecky, P. Pávek, A. Libra, 2004, Reproductive toxicology.

Examination of the Functional Activity of P-glycoprotein in the Rat Placental Barrier Using Rhodamine 123

Milan Nobilis, Martin Kopecky, Hana Sklenarova, 2003, Journal of Pharmacology and Experimental Therapeutics.

Expression and Transport Activity of Breast Cancer Resistance Protein (Bcrp/Abcg2) in Dually Perfused Rat Placenta and HRP-1 Cell Line

P. Pávek, M. Ceckova, Z. Vackova, 2006, Journal of Pharmacology and Experimental Therapeutics.